Australia's V2Food Acquires US-Based Daring Foods, Partners with Ajinomoto for Clean-Protein Products

Viatris Inc reported Q2 2025 revenues of $3.58 billion, beating estimates, despite a 6% decline YoY. The company's adjusted EPS of $0.62 exceeded expectations, and adjusted EBITDA was $1.08 billion, down 11% YoY. Viatris returned over $630 million to shareholders YTD, including $350 million in share buybacks. The company reiterated its 2025 financial guidance and is committed to its strategic priorities, including a focus on dermatology, ophthalmology, and gastroenterology, and a robust late-stage pipeline.

Viatris Inc. (Nasdaq: VTRS) reported strong second-quarter 2025 financial results, exceeding analyst expectations despite a year-over-year (YoY) decline in total revenues. The company's adjusted earnings per share (EPS) of $0.62 and adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) of $1.08 billion were also higher than anticipated. Additionally, Viatris returned over $630 million to shareholders year-to-date (YTD), including $350 million in share buybacks.

The company's total revenues for the second quarter 2025 were $3.58 billion, a 6% decline YoY. However, this was primarily driven by the negative Indore Impact. Excluding this impact, total revenues increased by 3% on a divestiture-adjusted operational basis compared to the same period last year. The company's adjusted EPS of $0.62 was up 10% YoY, while adjusted EBITDA was $1.08 billion, down 11% YoY.

Viatris's strong performance in the second quarter was driven by robust net sales in Greater China and Emerging Markets, as well as growth in certain key brands in Developed Markets. The company generated approximately $79 million in new product revenues in the quarter.

The company's CEO, Scott A. Smith, stated, "We delivered a strong second quarter and continued to make meaningful progress against our key 2025 strategic priorities. Our results reflect the strength and resilience of our diversified global business, and our late-stage pipeline continues to advance with encouraging momentum." The company's CFO, Doretta Mistras, added, "Our second-quarter results exceeded our expectations, and we continue to execute with financial discipline—delivering strong operational performance, reaffirming all key elements of our 2025 financial guidance ranges and building momentum into the second half of the year."

Viatris reiterated its 2025 financial guidance ranges across all metrics, expecting to be in the top half of the range for total revenues and adjusted EPS. The company is committed to returning significant capital to shareholders and remains focused on driving commercial execution, investing in strategic accretive in-market business development opportunities, and positioning itself for sustainable growth in 2026 and beyond.

References:
[1] https://www.prnewswire.com/news-releases/viatris-reports-second-quarter-2025-results-and-reiterates-2025-financial-guidance-302523749.html